Institution: The study is being conducted at hundreds of sites in the United States. A full list of sites at which Lung-MAP is currently being conducted is available on the website
Type: Multi-Center Trial
Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.
Dates: June 16, 2014 - January 1, 2022
Disease: Lung Cancer
Page last updated: February 23, 2021